Chromatographic analysis of metabolites was conducted on an Agilent 1290 infinity UPLC system (Agilent Technologies, Santa Clara, CA) equipped with an XDB-C18 column (2.1 × 100mm, 1.8μM, Agilent) following a previous report with minor modification (Zhao et al., 2017b (link)). The column temperature was maintained at 45 °C. The flow rate of mobile phase was 0.3mL/min with a gradient elution ranging from 2% to 98% acetonitrile containing 0.01% formic acid in 16 min run. The Q-TOFMS (Agilent 6500, Santa Clara, CA) was operated positive mode with electrospray ionization. Nitrogen was applied as cone gas and drying gas which was set at 350 °C. The nebulizer pressure was set at 35 psi, and capillary voltage was set at 3.5 kV. The MS/MS of pazopanib metabolites was performed in the targeted mode by collision energy of 20 eV. Relative quantitation of pazopanib metabolites was determined according to the abundance of peak area normalized by the internal standard. The quantitation of metabolites in urine, serum and feces was not precise without the standards which are not available.